Researchers found that a little-known group of immune cells is crucial for keeping cancer-fighting T cells active during immunotherapy. A small and difficult-to-study population of immune cells may play a much larger role in fighting cancer than previously understood. Researchers at the University of Manchester’s Cancer Research UK Manchester Institute found that activated dendritic cells […]This is a curated summary.